About Webinar Series
Genxovite hosts monthly webinars with industry experts to discuss the latest news, techniques, and regulations in the field of Regenerative Medicine.
In this enlightening and informative webinar, Dr. Sunny Kim will share their groundbreaking case study on the use of amniotic and umbilical cord (AMUC) tissue injections as a non-surgical treatment for wrist osteoarthritis (OA).
The FDA brought the lawsuit against the Cell Surgical Networks in 2018 in an attempt to assert regulatory authority over stem cell therapies. The agency argued that a physician's use of his patient's own stem cells as part of the medical treatment provided to the patient was equivalent to manufacturing a biological drug product and therefore subject to regulation by the FDA. The court rejected this argument last week, ruling that the surgical procedure does not create a new prescription drug. The court wrote: "The adipose tissue Defendants remove from patients clearly consists of human cells. And whatever is injected back into patients as part of Defendants' SVF Surgical Procedure and Expanded MSC Surgical Procedure certainly contains such cells." Introducing Our Guest Speaker, Sean Berman, The Most Qualified Person In The World To Discuss And Explain The Courts Latest Ruling